Researcher
Erika Vlieghe
- Keywords (University of Antwerp):Medicine
- Disciplines (University of Antwerp):Diagnostics, Immunology, Intensive care and emergency medicine, Laboratory medicine, Medical systems biology, Microbiology, Respiratory medicine, Tropical medicine, Other clinical sciences, Nursing
- See also: E Vlieghe (Institute of Tropical Medicine)
Affiliations
- Department of Clinical Sciences, Management (Research unit)
Member
From1 May 2019 → Today - Department of Clinical Sciences, Management (Research unit)
Member
From1 May 2019 → 25 Feb 2022 - Medical Services (Research unit)
Member
From1 May 2019 → 21 Apr 2021 - Global Health Institute (GHI) (Research group)
Member
From1 Jan 2019 → Today - Epidemiology and social medicine (ESOC) (Research group)
Member
From1 Feb 2017 → 31 Dec 2018 - Tropical Bacteriology (Research unit)
Member
From1 Aug 2004 → 5 Sep 2013 - Tropical Medicine (Research unit)
Member
From1 Aug 2004 → 25 May 2012
Projects
1 - 4 of 4
- Preparing First Line health care workers in the Flemish health care system for 'virus X', by setting up and validating a training package, using viral hemorrhagic fever as a model (FiLi-Vi-X).From1 May 2023 → TodayFunding: Flemish Resilience. Government of Flanders Recovery Plan - strengthening R&D
- Data-driven implementation of a behavioural Antimicrobial Stewardship approach and expert consultancy for a more appropriate use of antimicrobials in Europe (DRIVE-AMS).From1 Nov 2022 → TodayFunding: Other EU initiatives out of framework
- Infectious Diseases Education Advanced Level Intensive Training for a nEw Reality (IDEALiTER)From1 Oct 2022 → TodayFunding: Other EU initiatives out of framework
- Antimicrobial Resistance, Prescribing, and Consumption Data to Inform Country Antibiotic Guidance and Local Action (ADILA).From1 Apr 2022 → TodayFunding: Foreign public sponsor
Publications
11 - 20 of 90
- The emergence of travel-related infections in critical care units(2022)
Authors: Pieter-Jan Herten, Erika Vlieghe, Emmanuel Bottieau, Eric Florence, Philippe Jorens
Pages: 328 - 339 - Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients(2022)
Authors: An Bracke, Emilie De Hert, Michelle De bruyn, Karen Claesen, Gwendolyn Vliegen, Alexandra Vujkovic, Lida van Petersen, Fien De Winter, An Hotterbeekx, Isabel Brosius, et al.
Pages: 4 - 11 - Assessing the impact of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) on hospital antimicrobial stewardship programmes(2021)
Authors: Ann Versporten, Helene Vermeulen, Erika Vlieghe, Herman Goossens
- Clinical and laboratory features of Strongyloides stercoralis infection at diagnosis and after treatment(2021)
Authors: Dora Buonfrate, Andrea Fittipaldo, Erika Vlieghe, Emmanuel Bottieau
Pages: 1621 - 1628 - Nonautomated blood cultures in a low-resource setting(2021)
Authors: Sien Ombelet, Marjan Peeters, Chhundy Phe, Achilleas Tsoumanis, Chun Kham, Syna Teav, Erika Vlieghe, Thong Phe, Jan Jacobs
Pages: 612 - 621 - Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe)(2021)
Authors: Ann Versporten, Erika Vlieghe, Herman Goossens, Andi Koraqi, Iris Hoxha, Silva Tafaj, Wanda Cornistein, Rodolfo Quiros, Martin Hojman, Lilit Ghazaryan, et al.
Pages: 1614 - 1624 - Time of administration of rabies immunoglobulins and adequacy of antibody response upon post-exposure prophylaxis(2021)
Authors: Patrick Soentjens, Mieke Croughs, Christoph Burm, Steven Declerq, Jan Clerinx, Ula Maniewski, Steven Van den Broucke, Caroline Theunissen, Ralph Huits, Isabel Brosius, et al.
Pages: 91 - 97 - Leptospirose bij een geriatrische patiënt(2020)
Authors: A. Bertels, V. Mertens, Greta Moorkens, Erika Vlieghe
Pages: 906 - 911 - Clinical management of Argentine hemorrhagic fever using ribavirin and favipiravir, Belgium, 2020(2020)
Authors: Ioannis Veliziotis, Alain Roman, Delphine Martiny, Gerlind Schuldt, Marc Claus, Nicolas Dauby, Sigi Van den Wijngaert, Charlotte Martin, Rakan Nasreddine, Claudia Perandones, et al.
Pages: 1562 - 1566 - A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19(2020)
Authors: Timothy Devos, Tatjana Geukens, Alexander Schauvlieghe, Kevin K. Arien, Cyril Barbezange, Myriam Cleeren, Veerle Compernolle, Nicolas Dauby, Daniel Desmecht, David Grimaldi, et al.